Cyclooxygenase-2 expression in bladder cancer and patient prognosis: results from a large clinical cohort and meta-analysis.
Aberrant overexpression of cyclooxygenase-2 (COX2) is observed in urothelial carcinoma of the bladder (UCB). Studies evaluating COX2 as a prognostic marker in UCB report contradictory results. We determined the prognostic potential of COX2 expression in UCB and quantitatively summarize the results w...
Guardado en:
Autores principales: | Maciej J Czachorowski, André F S Amaral, Santiago Montes-Moreno, Josep Lloreta, Alfredo Carrato, Adonina Tardón, Manuel M Morente, Manolis Kogevinas, Francisco X Real, Núria Malats, SBC/EPICURO investigators |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8c9cdda32d7e4331a6ed06a4928c4f4c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ARID1A alterations are associated with FGFR3-wild type, poor-prognosis, urothelial bladder tumors.
por: Cristina Balbás-Martínez, et al.
Publicado: (2013) -
Large-scale pathway-based analysis of bladder cancer genome-wide association data from five studies of European background.
por: Idan Menashe, et al.
Publicado: (2012) -
Risk prediction scores for recurrence and progression of non-muscle invasive bladder cancer: an international validation in primary tumours.
por: Moniek M Vedder, et al.
Publicado: (2014) -
Leptin expression is substantially correlated with prognosis of urinary bladder carcinoma
por: Mohamad Nidal Khabaz, et al.
Publicado: (2021) -
In situ click chemistry generation of cyclooxygenase-2 inhibitors
por: Atul Bhardwaj, et al.
Publicado: (2017)